AJANTA PHARMA LTD (AJP IN; Mkt Cap USD51m, CMP Rs199, Buy)
We recommend to BUY Ajanta Pharma with a price target of Rs.255:
- Above industry growth in the domestic market and strong export growth to drive revenues by 14%
- Investment in R&D to the tune of 6-7% of revenues to create pipeline for growth beyond FY12
- Institutional sales adds to credentials and could present earnings upsides
Debt repayment and rising ROE to raise valuations above historical averages.